The Role of Inflammatory Markers in the Diagnosis of Extraperitoneal Endometriosis

Abstract

ABSTRACT OBJECTİVE: This study was concerned with the examination of patients who underwent surgery for subcutaneous endometriosis in our clinic and the relationship between subcutaneous endometriosis and inflammatory markers. MATERİALS AND METHODS: Patient demographics and information on history and duration of previous surgery, lesion size, number of lesions, location, recurrence, symptoms, type and number of deliveries, recurrence status, and imaging method were recorded. Laboratory analysis recorded TSH, blood count (Hb), WBC, mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLR), monocyte/platelet ratio (MPR), lymphocyte/monocyte ratio (LMR), platelet/lymphocyte ratio (PLR) and CA -125 values of patients. RESULTS: The study included 28 patients and it was found that the mean age of the patients was 32.67±5.56 years. Five (17.9%) and 18 (64.3%) of the patients complained of a palpable mass and cyclic pain, respectively. Five patients (17.9%) were asymptomatic. Endometriosis associated with the scar line was localized in 18 (64.3%) of the patients. In three (10.7%) of the patients, the endometriosis was localized in the perineal line and in 7 (25%) of the patients in the rectus abdominis. No significant difference was found in the patients' routine laboratory results and inflammatory markers. CONCLUSION: In the present study, there was no significant association between the levels of inflammatory markers in patients who underwent surgery for subcutaneous endometriosis at different sites and with different symptoms.

Keywords

• Endometriosis
• scar line
• episiotomy line
• abdominal wall
• extraperitoneal
• inflammatory.

References

1. 1- de Almeida GJ, Migliore R, Kistenmacker FJN, Oliveira MM, Garcia RB, Bin FC, et al. Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report. Sao Paulo Med J 2018; 136: 586-90.
2. 2- Koninckx PR, Ussia A, Wattiez A, Zupi E, Gomel V. Risk Factors, Clinical Presentation, and Outcomes for Abdominal Wall Endometriosis. J Minim Invasive Gynecol 2018; 25: 342-3.
3. 3- Nominato NS, Prates LF, Lauar I, Morais J, Maia L, Geber S. Caesarean section greatly increases risk of scar endometriosis. Eur J Obstet Gynecol Reprod Biol 2010; 152: 83-5.
4. 4- Mistrangelo M, Gilbo N, Cassoni P, Micalef S, Faletti R, Miglietta C, et al. Surgical scar endometriosis. Surg Today 2014; 44(4): 767-72.
5. 5- Grigore M, Socolov D, Pavaleanu I, Scripcariu I, Grigore AM, Micu R. Abdominal wall endometriosis: an update in clinical, imagistic features, and management options. Med Ultrason 2017; 19: 430-7.
6. 6- Maillard C, Cherif Alami Z, Squifflet JL, Luyckx M, Jadoul P, Thomas V, et al. Diagnosis and Treatment of Vulvo-Perineal Endometriosis: A Systematic Review. Front Surg. 2021;8:637180.
7. 7- Tatli F, Gozeneli O, Uyanikoglu H, et al. The clinical characteristics and surgical approach of scar endometriosis: A case series of 14 women. Bosn J Basic Med Sci 2018; 18: 275-8.
8. 8- Sumathy S, Mangalakanthi J, Purushothaman K, et al. Symptomatology and Surgical Perspective of Scar Endometriosis: A Case Series of 16 Women. J Obstet Gynaecol India 2017; 67: 218-23.

9. 9- Youssef AT. The ultrasound of subcutaneous extrapelvic endometriosis. J Ultrason. 2020; 20(82): 176-80
10. 10- Medeiros F, Cavalcante DI, Medeiros MA, Eleuterio J, Jr. Fine-needle aspiration cytology of scar endometriosis: study of seven cases and literatüre review. Diagn Cytopathol 2011; 39(1): 18-21
11. 11- Corrêa G, Pina L, Korkes H, Guazzelli T, Kenj G, Toledo A. Scar endometrioma following obstetric surgical icisions: retrospective study on 33 cases and review of literature. Sao Paulo Med J 2009; 127(5): 270–7.
12. 12- Andres MP, Arcoverde FVL, Souza CCC, Fernandes LFC, Abrão MS, Kho RM. Extrapelvic Endometriosis: A Systematic Review. J Minim Invasive Gynecol 2020; 27(2): 373-89.
13. 13- Yela DA, Trigo L, Benetti-Pinto CL. Evaluation of cases of abdominal wall endometriosis at Universidade Estadual de Campinas in a period of 10 years. Rev Bras Ginecol Obstet 2017; 39: 403-7.
14. 14- Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018; 8(1): 10566
15. 15- Fan Y, Li X, Zhou XF, Zhang DZ, Shi XF. [Value of neutrophil lymphocyte ratio in predicting hepatitis B-related liver failure]. Zhonghua Gan Zang Bing Za Zhi 2017; 25: 726-31.
16. 16- Tokmak A, Yildirim G, Öztaş E, Akar S, Erkenekli K, Gülşen P, et al. Use of neutrophil-to-lymphocyte ratio combined with ca-125 to distinguish endometriomas from other benign ovarian cysts. Reprod Sci 2016; 23: 795-802.
17. 17- Cho S, Cho H, Nam A, Kim HY, Choi YS, Park KH, et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis. Fertil Steril 2008; 90: 2073-9.
18. 18- Kim SK, Park JY, Jee BC, Suh CS, Kim SH. Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score. Clin Exp Reprod Med 2014; 41: 151-7.
19. 19- Yavuzcan A, Cağlar M, Ustün Y, Dilbaz S, Ozdemir I, Yıldız E, et al. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. J Turk Ger Gynecol Assoc 2013; 14: 210-5.